Drooid Logo
Back to today’s briefing

Story perspectives

Esketamine Combines with Antidepressants: Hope for Depression

4/2/2025

40 9

1 of 1

Story summary
  • A groundbreaking study reveals that combining esketamine with SSRIs or SNRIs offers hope for those battling treatment-resistant depression. Esketamine swiftly lowers hospitalization and mortality rates with SNRIs and significantly reduces suicide attempts alongside SSRIs. Tailoring treatment to individual patient needs is crucial for achieving the best results in overcoming major depressive disorder.